The Indian Pharmaceutical Giant ‘SII’ to cut Covishield production by 50 percent
_Vinayak Barot New Delhi: Amid the rising ‘Omicron’ threat in the world, the Indian pharmaceutical giant Serum Institute of India (SII) has decided to cut the covishield vaccine production by 50 percent. Chief Executive officer of SII Adar Poonawalla said that “The Company has decided to cut the production by 50 percent as Company has […]
